Nurix Therapeutics, Inc.
BIFUNCTIONAL COMPOUNDS FOR DEGRADING BTK VIA UBIQUITIN PROTEOSOME PATHWAY

Last updated:

Abstract:

The present invention relates to compounds useful for degrading BTK via a ubiquitin proteolytic pathway. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.

Status:
Application
Type:

Utility

Filling date:

4 Feb 2020

Issue date:

12 May 2022